Aptose Bioscns Cmn (NASDAQ:APTO) shares traded during most recent session to reach at the closing price of $1.9. The stock exchanged hands on average of 246.13 Million shares, yielding a market cap of $67.45 Million. Wall Street analysts covering the stock are projecting that the stock will reach $4.89 within the next 52-weeks. The mean target projections are based on 1 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have Aptose Bioscns Cmn (NASDAQ:APTO) high price target of $4.89 and with a conservative view have low price target of $4.89.
H.C. Wainwright “Maintained” Aptose Bioscns Cmn (NASDAQ:APTO) in a research note issued to investors on 12/13/17 to Buy with price target of $6.
Additionally on 9/07/17 H.C. Wainwright “Upgrades” Aptose Bioscns Cmn (NASDAQ:APTO) to Buy setting price target at $ and on 6/08/17 Rodman & Renshaw “Initiates Coverage On” the stock to Neutral at $1. Furthermore on 6/13/16 Roth Capital “Upgrades” the stock to Buy at $8.
On the other hand the company has Relative Strength Index (RSI 14) of 24.18 along with Average True Range (ATR 14) of 0.19, Consequently Aptose Bioscns Cmn (NASDAQ:APTO)’s weekly and monthly volatility is 12.83%, 6.89% respectively. The company’s beta value is at 1.93.
In terms of Buy, Sell or Hold recommendations, Aptose Bioscns Cmn (NASDAQ:APTO) has analysts’ mean recommendation of 2. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
According to analysts Aptose Bioscns Cmn (NASDAQ:APTO)’s minimum EPS for the current quarter is at $-0.2 and can go high up to $-0.1. The consensus mean EPS for the current quarter is at $-0.14 derived from a total of 3 estimates from the analysts who have weighed in on projected earnings. However the company reported $-0.24 earnings per share for the same quarter during last year.
Previously Aptose Bioscns Cmn (NASDAQ:APTO) reported $-0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $-0.15 by $0.04. The company posted an earnings surprise of 26.7%.
Currently Aptose Bioscns Cmn (NASDAQ:APTO)’s shares owned by insiders are 20.4%, whereas shares owned by institutional owners are 35.1%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded 2.05%.
Aptose Bioscns Cmn (NASDAQ:APTO)’s trailing twelve month revenues are $0, whereas its price to sales ratio for the same period is 0. Its book value per share for the most recent quarter is $0.5 while its price to book ratio for the same period is 3.8, as for as the company’s cash per share for the most recent quarter is $0.52, however its price to cash per share ratio for the same period is 3.67. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.